Search Results for:
Professional development workshop: “How to best plan your career: Tips and tricks from the experts”
This series will provide expert advice and practical tips to support the personal and professional development of transplant professionals at all career stages. The topics of this series were selected based on the results of an educational needs assessment recently conducted by ESOT.
About EF CLIF
The European Foundation for the Study of Chronic Liver Failure (EF CLIF) is a private non-profit organization connecting biomedical researchers and healthcare professionals with each other, with patients and patient associations, and with society. The fundamental purpose of EF CLIF, reflected in its founding Statements of 2015, is to advance knowledge and promote research and
Membership
The European Medicines Agency (EMA) announcements
ESOT would like to share two recent transplant-related announcements made by the EMA. EMA consultation: iBox Scoring System in kidney transplant patients The EMA has published for public consultation a “draft qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients”.
ETAHP Call for Nominations
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
Info Session on the ESOT Mentorship Programme!
Do you want to learn more on the ESOT Mentorship Programme before applying either as mentors or mentees? Do you have any doubts on this new opportunity for professional development? Join us at the Info Session on Tuesday 18 October at 18:30 CEST! Luca Toti, Chair of the Education Committee, and Liset Pengel, Vice-Chair, will
NEW WEBINAR: Changing to an Opt-Out Consent System for Organ Donation in Three European Countries
The webinar will investigate the recently implemented organ donation opt-out systems in UK and the Netherlands to assess the steps that were taken to achieve this.
HESPERIS Course 2023
CareDx’s AlloSeq cfDNA Represents a Minimally Invasive, Accurate Method to Detect Graft Injury as a Leading Solution for Transplant Patient Management in Europe
CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.
